500
0
0

November is Lung Cancer Awareness Month. Explore both sides of lung cancer diagnosis →

Skip to Content
Lung Cancer Europe | Advocacy and Access for Lung Cancer in Europe
🔍
Overview
Contact
Our Board
Newsletter
Brand hub
Our Partners
Supporters & Funding
Annual Reports
SCLC Report
Policy and resources
English
Our Members
Lung Cancer Europe | Advocacy and Access for Lung Cancer in Europe
🔍
Overview
Contact
Our Board
Newsletter
Brand hub
Our Partners
Supporters & Funding
Annual Reports
SCLC Report
Policy and resources
English
Our Members
🔍
Folder: Who We Are
Back
Overview
Contact
Our Board
Newsletter
Brand hub
Our Partners
Supporters & Funding
Folder: Reports
Back
Annual Reports
SCLC Report
Policy and resources
English
Back
Our Members
No results found
Treatment and research Web Team 28/10/2026 Treatment and research Web Team 28/10/2026

ESMO 2026: a new chapter in small cell lung cancer treatment

Read More
Living with lung cancer Web Team 23/10/2026 Living with lung cancer Web Team 23/10/2026

The financial toxicity of lung cancer in Europe: survey findings presented at ESMO

Read More
Lung Cancer Europe and members Web Team 11/09/2026 Lung Cancer Europe and members Web Team 11/09/2026

Lung Cancer Europe at WCLC 2026, Seoul

Read More
Lung Cancer Europe and members Web Team 08/09/2026 Lung Cancer Europe and members Web Team 08/09/2026

Lung Cancer Europe at ERS Congress 2026

Read More
Treatment and research Web Team 12/06/2026 Treatment and research Web Team 12/06/2026

GLP-1 drugs and lung cancer: what the ASCO 2026 evidence shows, and what it does not

Read More
Lung Cancer Europe and members Web Team 07/06/2026 Lung Cancer Europe and members Web Team 07/06/2026

Lung Cancer Europe at the World Cancer Series Europe 2026

Read More
Prevention and risk Web Team 06/06/2026 Prevention and risk Web Team 06/06/2026

Lung cancer in women: what ASCO 2026 and a new Nature review tell us

Last week, two things converged. The world's largest oncology conference brought thousands of researchers to Chicago. And Nature published an article declaring lung cancer in women a distinct disease. The timing was not coincidental.

Read More
Lung Cancer Europe and members Web Team 29/05/2026 Lung Cancer Europe and members Web Team 29/05/2026

Lung Cancer Europe is at ASCO for the first time. Here is why.

Read More

With Thanks to Our Supporters

Lung Cancer Europe is grateful to the partners who share our commitment to people affected by lung cancer. Their support helps us turn our mission into action across research, education and advocacy.

Accord Healthcare Amgen Bayer AstraZeneca BeOne Medicines BioNTech Blueprint Medicines Bristol Myers Squibb Boehringer Ingelheim Daiichi Sankyo Genmab Gilead Johnson & Johnson Lilly Merck Group MSD Novartis Novocure Pfizer PharmaCosmos PharmaMar Pierre Fabre Regeneron Roche Takeda Thermo Fisher

Connect with us on LinkedIn

Stay in the loop

You can subscribe to updates from Lung Cancer Europe by signing up to our monthly newsletter below. Our newsletter goes out on the 1st of every month and we also send out news bulletins and updates.

By signing up, you agree to receive emails from Lung Cancer Europe. You can unsubscribe at any time. Read our Privacy Policy to learn how we handle your data.

PRIVACY POLICY
COMPLIANCE

© Lung Cancer Europe 2026 | Designed by Laura Jones